
Funding rounds intensify as crisis management adds up to VCs' investment criteria
Investors are expecting a bulk of changes in the ‘new normal’, making it harder for cash-strapped startups.
During the first five months of the year, some of Singapore’s startups still managed to fundraise despite trying times. One of the latest movement on this scene is biotech startup RWDC Industries, which just closed its series B funding of $188.42m (US$133m) from Vickers Venture Partners, energy and resources company Flint Hills Resources, CPV/CAP Pensionskasse Coop, and International SA.
During the first five months of the year, some of Singapore’s startups still managed to fundraise despite trying times. One of the latest movement on this scene is biotech startup RWDC Industries, which just closed its series B funding of $188.42m (US$133m) from Vickers Venture Partners, energy and resources company Flint Hills Resources, CPV/CAP Pensionskasse Coop, and International SA.